Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia

Published:2018-03-22 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chen Yu-An,Lin Ying-Ju,Lin Cheng-Li,Lin Hwai-Jeng,Wu Hua-Shan,Hsu Hui-Ying,Sun Yu-Chen,Wu Hui-Yu,Lai Chih-Ho,Kao Chia-Hung

Funder

Ministry of Health and Welfare

Ministry of Science and Technology, Taiwan

Chang Gung Memorial Hospital, Linkou

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference43 articles.

1. The current evidence on statin use and prostate cancer prevention: are we there yet?;Alfaqih;Nat. Rev. Urol.,2017

2. Statin use in prostate cancer: an update.;Babcook;Nutr. Metab. Insights,2016

3. Prostate cancer prevention by nutritional means to alleviate metabolic syndrome.;Barnard;Am. J. Clin. Nutr.,2007

4. Statin use and the risk of prostate cancer: a metaanalysis of 6 randomized clinical trials and 13 observational studies.;Bonovas;Int. J. Cancer,2008

5. Statins and cancer risk: a confounded association.;Bonovas;Gastroenterology,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation;Biomedicine & Pharmacotherapy;2024-08

2. Statins as anti‐tumor agents: A paradigm for repurposed drugs;Cancer Reports;2024-05

3. Targeting lipid metabolism in metastatic prostate cancer;Therapeutic Advances in Medical Oncology;2023-01

4. Statin Use Is Associated with Better Prognosis of Patients with Prostate Cancer after Definite Therapies: A Systematic Review and Meta-Analysis of Cohort Studies;Journal of Oncology;2022-11-15

5. Increased Risk of Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Nationwide Population-Based Cohort Study;International Journal of Environmental Research and Public Health;2022-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3